Intervention Review

Immunotherapy for advanced renal cell cancer

  1. Chris Coppin1,*,
  2. Franz Porzsolt2,
  3. Michael Autenrieth3,
  4. Julia Kumpf4,
  5. Andrew Coldman5,
  6. Timothy Wilt6

Editorial Group: Cochrane Prostatic Diseases and Urologic Cancers Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 17 MAY 2006

DOI: 10.1002/14651858.CD001425.pub2

How to Cite

Coppin C, Porzsolt F, Autenrieth M, Kumpf J, Coldman A, Wilt T. Immunotherapy for advanced renal cell cancer. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD001425. DOI: 10.1002/14651858.CD001425.pub2.

Author Information

  1. 1

    Powell River, BC, Canada

  2. 2

    Ludwig-Maximilians - University of Munich, Evidence-Based Health Care Working Group, Munich, Germany

  3. 3

    Universität Ulm, Dept of Medicine, Ulm, Baden-Wurttemberg, Germany

  4. 4

    Univeristat Ulm, Ulm, Baden-Wurttemberg, Germany

  5. 5

    British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  6. 6

    VAMC, General Internal Medicine (111-0), Minneapolis, Minnesota, USA

*Chris Coppin, C-25 Scotch Fir Point Road, RR3, Powell River, BC, V8A 5C1, Canada. chris.coppin@hotmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 OCT 2008

SEARCH

  1. Current Version

    Immunotherapy for advanced renal cell cancer

    Chris Coppin, Franz Porzsolt, Michael Autenrieth, Julia Kumpf, Andrew Coldman and Timothy Wilt

    Article first published online: 8 OCT 2008 | DOI: 10.1002/14651858.CD001425.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Immunotherapy for advanced renal cell cancer

    C Coppin, F Porzsolt, J Kumpf, A Coldman and T Wilt

    Article first published online: 18 OCT 2004 | DOI: 10.1002/14651858.CD001425